Despite their recent and considerable underperformance, market analysts stress the need for clients to evaluate health care equities by their long-term returns.
"The underlying story behind health care is strong," Morningstar analyst Robert Goldsborough says. "Despite health care reform, there is a lot arguing broadly for health care."
Although they all posted negative returns in the past year, the sector's five leading ETFs beat the three-, five- and 10-year performance numbers of the S&P 500, according to Morningstar.
The broad-based index posted annualized gains of 11.95% over three years, 11.73% over five years and 7.10% over 10 years. The one-year return amounted to a gain of 0.76%.
The sector's top ETF performer during the past five years, PowerShares Dynamic Pharmaceuticals (PJP), illustrates the long-term growth trend for health care equities. Although the fund posted a one-year loss of 14.74% through April 25, it also enjoyed a five-year return of 22.98%.
The sector's largest ETF, the $12.76 billion Health Care Select Sector SPDR (XLV), incurred a one-year loss of 2.28% but returned nearly 10.73% return over the past 10 years.
For this list, we considered all health sector ETFs and ranked them by their five-year annualized returns.
All data from Morningstar.
This story is part of a 30-30 series on smart ETF strategies. A version of this story was originally published on March 15.
2
-
AI is being used not only to locate prospects, but also to help advisors show their value on the way to signing a new client.
1h ago -
Speakers on an "AI & Compliance" panel at Financial Planning's ADVISE AI conference say advisors can use existing basic compliance principles to make sure their AI use doesn't step on any regulatory landmines.
October 29 -
The Federal Open Market Committee voted to reduce interest rates by 25 basis points Wednesday, but the emergence of dissents on the committee makes the chance of another quarter-point cut in December less certain.
October 29 -
Financial advisors know how to guide clients through volatility, but the math displaying the portfolio risks of AI may present an altogether different challenge.
October 29 -
Unpopular compensation changes at UBS continue to drive advisor attrition, costing the firm billions in client assets. But despite the outflows, executives say the new policy is helping improve UBS' profits.
October 29 -
It isn't just the data itself that firms should be focused on, panelists at ADVISE AI said, but how that data is connected and how relevant it still is.
October 29





